Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension (BOSAPAH)

This study has been completed.
Information provided by (Responsible Party):
Robert P Baughman, University of Cincinnati Identifier:
First received: December 26, 2007
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):